Waveform Capnography Compared to Colorimetric Carbon Dioxide Detection During Tracheal Intubation of Critically Ill Adults
WAVE
Waveform Capnography and Colorimetric Carbon Dioxide Detection During Tracheal Intubation of Critically Ill Adults
1 other identifier
observational
1,332
1 country
6
Brief Summary
This study will compare the sensitivity and specificity of waveform capnography versus colorimetric carbon dioxide detection to identify tracheal placement of the endotracheal tube during intubation of critically ill adults.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2025
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 11, 2025
CompletedFirst Posted
Study publicly available on registry
April 18, 2025
CompletedStudy Start
First participant enrolled
April 21, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2027
November 4, 2025
October 1, 2025
1.6 years
April 11, 2025
October 31, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sensitivity of the test of exhaled carbon dioxide to detect a endotracheal tube positioned in the trachea.
The co-primary endpoints are the sensitivity and specificity of each test (against the reference standard) to accurately detect the tube location. The sensitivity of each CO2 detection method describes the probability that the CO2 detection method is consistent with a tube location in the trachea for a patient who has an endotracheal tube located inside the trachea. The co-primary outcomes are a direct comparison of the sensitivity and specificity between the two index tests using McNemar's test with a two-sided P value with a significance level of 0.05. The McNemar's test is well-suited to paired data where both diagnostic tests are applied to the same patients. We will also present the absolute between-group difference with 95% confidence intervals.
From intubation until 7 breaths from the ventilator are delivered, approximately 1 minute
Secondary Outcomes (1)
Specificity of the test of exhaled carbon dioxide to detect a endotracheal tube positioned outside of the trachea.
From intubation until 7 breaths from the ventilator are delivered, approximately 1 minute
Study Arms (1)
Critically ill adults undergoing emergency tracheal intubation
Adult patients who are undergoing emergency intubation in the ED and ICU
Interventions
All patients will undergo colorimetric carbon dioxide (CO2) detection. The reading will be assessed by a clinician at the bedside who will answer yes or no to the following question, asked after 7 breaths have been delivered following intubation: "Is the color change consistent with a tube located in the trachea?"
All patients will undergo waveform capnography. The reading will be assessed by a clinician at the bedside who will answer yes or no to the following question, asked after 7 breaths have been delivered following intubation: " Is the waveform consistent with a tube located in the trachea?"
Eligibility Criteria
Critically ill adult patients undergoing emergency intubation
You may qualify if:
- Patient is located in a participating unit (ED or ICU)
- Patient is undergoing tracheal intubation.
- The clinician intends to use an exhaled CO2 detection device to confirm tracheal placement of the tube.
You may not qualify if:
- Patient is known to be a prisoner
- Patient is known to be \< 18 years old
- A responsible clinician has determined that sole use of either waveform capnography or colorimetric testing is required for optimal care of the patient.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Brian Driverlead
Study Sites (6)
Lahey Hospital & Medical Center
Burlington, Massachusetts, 01805, United States
Hennepin Healthcare
Minneapolis, Minnesota, 55415, United States
Duke University School of Medicine
Durham, North Carolina, 27710, United States
Wake Forest School of Medicine
Winston-Salem, North Carolina, 27157, United States
The Ohio State University College of Medicine
Columbus, Ohio, 43210, United States
Oregon Health and Sciences University
Portland, Oregon, 97239, United States
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Co-Principal Investigator
Study Record Dates
First Submitted
April 11, 2025
First Posted
April 18, 2025
Study Start
April 21, 2025
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
January 1, 2027
Last Updated
November 4, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
- Time Frame
- From 12 months after publication until 48 months after publication
- Access Criteria
- Researchers testing a hypothesis outlined in an institutional review board approved protocol can access the full de-identified dataset. These data can be accessed by emailing the corresponding author. A signed data access agreement will be required.
The authors will share the full de-identified dataset beginning 12 months after publication until 48 months after publication for researchers testing a hypothesis outlined in an institutional review board approved protocol. These data can be accessed by emailing the corresponding author. A signed data access agreement will be required.